Insider Trading Alert - CERN, MJN And AL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 4, 2014, 99 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $25.55 to $17,507,243.40.

Highlighted Stocks Traded by Insiders:

Cerner (CERN) - FREE Research Report

Zollars William D, who is Director at Cerner, sold 7,900 shares at $63.30 on Nov. 4, 2014. Following this transaction, the Director owned 65,666 shares meaning that the stake was reduced by 10.74% with the 7,900-share transaction.

The shares most recently traded at $63.29, down $0.01, or 0.02% since the insider transaction. Historical insider transactions for Cerner go as follows:

  • 4-Week # shares sold: 9,200
  • 12-Week # shares sold: 9,200
  • 24-Week # shares sold: 9,200

The average volume for Cerner has been 1.7 million shares per day over the past 30 days. Cerner has a market cap of $21.6 billion and is part of the technology sector and computer software & services industry. Shares are up 13.89% year-to-date as of the close of trading on Tuesday.

Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. The company has a P/E ratio of 50.6. Currently, there are 18 analysts who rate Cerner a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CERN - FREE

TheStreet Quant Ratings rates Cerner as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cerner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mead Johnson Nutrition (MJN) - FREE Research Report

Singer Robert S, who is Director at Mead Johnson Nutrition, sold 6,000 shares at $100.56 on Nov. 4, 2014. Following this transaction, the Director owned 12,676 shares meaning that the stake was reduced by 32.13% with the 6,000-share transaction.

The shares most recently traded at $98.98, down $1.58, or 1.59% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 17,601
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 37,601
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 104,684

The average volume for Mead Johnson Nutrition has been 1.4 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $20.3 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 17.49% year-to-date as of the close of trading on Tuesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.5%. The company has a P/E ratio of 29.9. Currently, there are 5 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Mead Johnson Nutrition Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Air Lease (AL) - FREE Research Report

Baer Marc H, who is Evp at Air Lease, sold 2,000 shares at $36.71 on Nov. 4, 2014. Following this transaction, the Evp owned 132,249 shares meaning that the stake was reduced by 1.49% with the 2,000-share transaction.

The shares most recently traded at $37.12, up $0.41, or 1.12% since the insider transaction. Historical insider transactions for Air Lease go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 2,000

The average volume for Air Lease has been 722,300 shares per day over the past 30 days. Air Lease has a market cap of $3.8 billion and is part of the services sector and diversified services industry. Shares are up 17.99% year-to-date as of the close of trading on Tuesday.

Air Lease Corporation is engaged in the purchase and leasing of commercial jet transport aircraft to airlines worldwide. The company also sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies, and airlines. The stock currently has a dividend yield of 0.33%. The company has a P/E ratio of 17.0. Currently, there are 7 analysts who rate Air Lease a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AL - FREE

TheStreet Quant Ratings rates Air Lease as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Air Lease Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%